Luca Liistro > Chiomenti > Milan, Italy > Lawyer Profile
VIA VERDI 2
- Go to...
Partner - Corporate - M&A
Luca advises Italian and international clients on extraordinary transactions on commercial law and contracts matters with a focus on assisting entrepreneurs and multinational companies operating in various industrial sectors.
Luca has gained a wealth of experience in real estate law sectors that have specific features such as hotels, and “trophy assets”. He is also one of the coordinators of the pharma, healthcare and life sciences practices of the Firm.
Luca Liistro joined the Firm in 2001 and became a Partner in 2013. After completing his LL.M., he was a Foreign Associate at Skadden, Arps, Slate, Meagher & Flom, LLP in New York between 2006-2007. He worked for the Firm’s New York office from 2007 to 2009.
Member of the Milan Bar (Italy)
Graduated in Law, University of Palermo, 2001; LL.M., International Business and Trade Law, Fordham University, School of Law, New York, NY (USA), 2006.
The recent work of Chiomenti‘s pharmaceutical, healthcare and life sciences practice involved the review of authorisations and licences to sell medicinal products, clinical trials of products and vaccines, and several pharmaceutical market-related procedures. Heading up the firm’s pharma business unit, Luca Liistro advises on the particular requirements of the pharmaceutical and healthcare sectors; administrative law head Filippo Brunetti routinely acts for both pharmaceutical manufacturers and medical devices companies.
Top Tier Firm Rankings
- Administrative and public law
- Banking and finance: Borrower side
- Banking and finance: lender or arranger side
- Capital markets: Equity
- Commercial, corporate and M&A
- EU and competition law
- Industry focus: Luxury goods
- Industry focus: Retail
- Private equity
- Real estate and construction
- Restructuring and insolvency
- Capital markets: Debt
- Data privacy and data protection
- Dispute resolution
- Industry focus: Energy
- Industry focus: Manufacturing
- Industry focus: TMT
- Investment funds
- Industry focus: Food
- Industry focus: Healthcare and life sciences
- Intellectual property
- Banking and finance: Bank regulatory